| Name | GENinCode |
|---|---|
| Epic | GENI |
| Isin | GB00BL97B504 |
| Industry | Medical Equipment and Services |
| Latest share price | 3.25p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £5.75 | Debt ratio | n/a |
| Shares in issue | 176.96 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -526.02 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -6.97 | 52-week high / low | 3.10p / 9.63p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | GENinCode |
|---|---|
| Address | One St. Peters Square, Manchester, United Kingdom, M2 3DE |
| Telephone | +44 186 5955 847 |
| Website | http://www.genincode.com |
| Director | Position |
|---|---|
| Mr Matthew Heaton Walls | CEO |
| Mr Paul Andrew Peter Foulger | CFO |
| Mr Jordi Puig Gilberte | COO |
| Mr Felix Frueh | Non-Executive Director |
| Mr William Edward Rhodes | Non-Executive Chairman |
| Mr Sergio Olivero Rigau | Independent Non-Executive Director |
| Mr Huon Gray | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 0.29 | 0.31 | 0.19 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 0.99 | 1.31 | 0.24 |
| Inventory / work in progress | 0.08 | 0.02 | 0.01 |
| Trade and other receivables | 0.58 | 0.72 | 0.4 |
| Cash and equivalents | 2.48 | 9.73 | 14.55 |
| Other current assets and asset held for resale | 0.04 | 0.02 | n/a |
| Total of all assets | 4.19 | 11.8 | 15.21 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 2.47 | 2.15 | 0.83 |
| Long term liabilities | 0.42 | 1.75 | 0.66 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 2.9 | 3.9 | 1.49 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 1.29 | 7.9 | 13.72 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 0.96 | 0.96 | 0.96 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -15.51 | -8.49 | -2.94 |
| Share premium account | 15.55 | 15.55 | 15.55 |
| Total equity | 1.29 | 7.9 | 13.72 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -7.15 | -5.9 | -4.15 |
| Pre-tax profit | -7.02 | -5.75 | -4.14 |